Navigation Links
Codeine-based painkillers to be used cautiously

Pharmacists advise that people should be aware of the dangers of overusing the opium-based drug codeine found in many painkillers.//

People should consult their pharmacist before taking painkillers. This was suggested by the Irish Pharmaceutical Union (IPU).

“These medicines, which are available directly from your pharmacist, are very effective in relieving the symptoms of headaches and other forms of pain. Irish pharmacists often recommend these medicines to treat pain,” Darragh O’Loughlin, a Galway pharmacist, said.

“However, prolonged regular use, except under medical supervision, may lead to physical and psychological dependence, addiction and result in withdrawal symptoms, such as restlessness and irritability once the patient stops taking the medication. Pharmacists always recommend consulting your doctor if symptoms have not eased with a couple of days’ treatment using over-the-counter medicines.”

Some over-the-counter medicines like Solpadeine and Nurofen Plus contain codeine, according to the union, representing 1,600 pharmacists.

“Patients who use pain relievers regularly over a prolonged period of time may experience rebound headaches. Pain relievers offer quick relief for occasional headaches. But there’s a limit – taking pain medication more than two or three days a week may actually contribute to headaches rather than easing them. It’s a cycle known as rebound headaches,” he said.

“Many types of pain relievers can contribute to rebound headaches, if you exceed the recommended daily dose.” According to him, rebound headaches were more common in people taking a medicine having a combination of codeine, caffeine and paracetamol as ingredients.

“Excessive use of some types of pain medication also may cause stomach ulcers, liver damage and kidney problems. Patients with symptoms persisting for more than three days should contact their pharmacist or doctor for best advice on a course of treatment,” he said.


Related medicine news :

1. Drug dilemma confronts users of painkillers
2. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: